Johnson & Johnson expands project that aims to predict, prevent diseases
March 22, 2016 | Written By: Tribune news services | Source: ChicagoTribune Johnson & Johnson has ramped up its ambitious project to learn how to predict who will develop particular diseases and find therapies to prevent or stop the disease early, when it’s most treatable. Since the health care giant announced its... More
Researchers Tease Apart a Pathway Certain Cancer Cells Use to Replicate
Thursday, January 28th, 2016 | Source: BUSM A new “player” in the way certain aggressive cancer cells may reproduce has been identified. It is hoped that these findings may lead to the identification of new cancer targets and may ultimately lead to new therapeutics. The telomere is a repetitive DNA sequence that... More
Epigenetic Regulation of Metastatic Breast Cancer Progression Could Guide Prognosis and Future Therapies
Friday, January 8th, 2016 | Source: BUSM A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for the development of future breast cancer therapies. These findings by Boston University School of... More
Cancer Center Director Named
Thursday, November 5th, 2015 | Source: BUSM Avrum Spira, MD, MSc, has been named Director of the Boston University Cancer Center, replacing Douglas Faller, MD, PhD, who stepped down last November to focus on oncology drug development. Spira, a Professor of Medicine, Pathology and Bioinformatics, and the Alexander Graham Bell Professor in... More